drug · protein
patient view →angiotensin II
Phase 1updated 2mo agoby Platform Therapeutics Inc🔗 ChEMBL
Phase 1community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 6 investigational indications.
targets
Type-1 angiotensin II receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that